DOCSLIB.ORG

Β8 Integrin Expression and Activation of TGF-Β by Intestinal Dendritic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

β8 Integrin Expression and Activation of TGF- β by Intestinal Dendritic Cells Are Determined by Both Tissue Microenvironment and Cell Lineage This information is current as of September 25, 2021. Mathilde Boucard-Jourdin, David Kugler, Marie-Laure Endale Ahanda, Sébastien This, Jaime De Calisto, Ailiang Zhang, J. Rodrigo Mora, Lynda M. Stuart, John Savill, Adam Lacy-Hulbert and Helena Paidassi J Immunol published online 1 August 2016 Downloaded from http://www.jimmunol.org/content/early/2016/07/30/jimmun ol.1600244 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2016/07/30/jimmunol.160024 Material 4.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published August 1, 2016, doi:10.4049/jimmunol.1600244 The Journal of Immunology b8 Integrin Expression and Activation of TGF-b by Intestinal Dendritic Cells Are Determined by Both Tissue Microenvironment and Cell Lineage Mathilde Boucard-Jourdin,*,†,‡,x,{,1 David Kugler,‖,1 Marie-Laure Endale Ahanda,*,†,‡,x,{ Se´bastien This,*,†,‡,x,{ Jaime De Calisto,# Ailiang Zhang,** J. Rodrigo Mora,†† Lynda M. Stuart,‖ John Savill,** Adam Lacy-Hulbert,‖,2 and Helena Paidassi*,†,‡,x,{,2 Activation of TGF-b by dendritic cells (DCs) expressing avb8 integrin is essential for the generation of intestinal regulatory T cells (Tregs) that in turn promote tolerance to intestinal Ags. We have recently shown that avb8 integrin is preferentially expressed by CD103+ DCs and confers their ability to activate TGF-b and generate Tregs. However, how these DCs become specialized for this vital function is unknown. In this study, we show that b8 expression is controlled by a combination of factors Downloaded from that include DC lineage and signals derived from the tissue microenvironment and microbiota. Specifically, our data demonstrate that TGF-b itself, along with retinoic acid and TLR signaling, drives expression of avb8 in DCs. However, these signals only result in high levels of b8 expression in cells of the cDC1 lineage, CD8a+, or CD103+CD11b2 DCs, and this is associated with epigenetic changes in the Itgb8 locus. Together, these data provide a key illustrative example of how microenvironmental factors and cell lineage drive the generation of regulatory avb8-expressing DCs specialized for activation of TGF-b to facilitate Treg generation. The Journal of Immunology, 2016, 197: 000–000. http://www.jimmunol.org/ endritic cells (DCs) serve a unique sentinel role in the (1, 2). Determining how DCs differentiate to carry out specialized body, surveying tissues, integrating peripheral cues, and functions is critical for our understanding of immunity in health and D instructing the adaptive immune system accordingly. DCs disease. can orchestrate powerful pathogen-directed immunity or regulate The intestine provides a particular challenge for the immune and suppress immune responses to self-associated or innocuous Ags, system, containing a high local concentration of microbes, includ- and the complexity of these roles is reflected in the diverse popula- ing commensals and potential pathogens, as well as diverse dietary tions of DCs found in different tissues and under different conditions and environmental Ags (3). To prevent inappropriate inflammatory by guest on September 25, 2021 responses to these mostly innocuous Ags, the mucosal immune *CIRI, Centre International de Recherche en Infectiologie, Universite´ de Lyon, system has robust immunoregulatory mechanisms that include 69365 Lyon, France; †INSERM, U1111, 69007 Lyon, France; ‡Ecole Normale Supe´r- regulatory lymphocytes, which reside in the mucosa and associ- ieure de Lyon, 69007 Lyon, France; xUniversite´ Claude Bernard Lyon 1, Centre International de Recherche en Infectiologie, Lyon, France; {CNRS, UMR5308, ated lymphoid organs and actively suppress immune responses to 69365 Lyon, France; ‖Benaroya Research Institute, Seattle, WA 98101; #Centro intestinal Ags (4). The best characterized of these are CD4+ Foxp3+ de Geno´mica y Bioinforma´tica, Facultad de Ciencias, Universidad Mayor, San- regulatory T cells (Tregs), which either originate in the thymus tiago 8580745, Chile; **Medical Research Council Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh (thymic or natural Tregs) or are generated in the periphery from EH16 4TJ, United Kingdom; and ††Gastrointestinal Unit, Massachusetts General naive CD4+ T cells (peripheral or adaptive Tregs). In the intestine, Hospital, Boston, MA 02114 peripheral Tregs are generated by DCs that constitutively acquire 1 M.B.-J. and D.K. contributed equally to this work. and present self and foreign Ags (5, 6), resulting in Ag-specific tol- 2 A.L.-H. and H.P. contributed equally to this work. erance (7). The generation of peripheral Tregs requires TGF-b,and ORCIDs: 0000-0002-2936-1649 (D.K.); 0000-0002-0861-1565 (M.-L.E.A.); 0000-0002- we and others have shown that an essential characteristic of DCs that 3927-1399 (J.D.C.); 0000-0002-6488-156X (A.Z.); 0000-0001-8819-0950 (J.R.M.); 0000-0003-2079-1586 (J.S.). generate Tregs is their ability to activate TGF-b from its inactive or Received for publication February 10, 2016. Accepted for publication June 30, 2016. latent precursor to an active form that can engage the TGF-b receptor This work was supported by Agence Nationale de la Recherche Grant ANR-13- (8, 9). This requires the action of a specific cell surface integrin, PDOC-0019, People Programme (Marie Sklodowska-Curie Actions) of the European avb8, and, underscoring the importance of this process, deletion of Union’s Seventh Framework Programme Research Executive Agency Grant PIIF- either the avorb8 subset from DCs results in failure to generate GA-2012-330432, the Mitchell Trust (to H.P.), National Institutes of Health Grant R01DK093695 (to A.L.-H.), a Crohn’s and Colitis Foundation of America grant intestinal Tregs and subsequent development of colitis (10, 11). (to A.L.-H.), and UK Medical Research Council Grant G0802069 (to J.S.). Recently, we have shown that expression of avb8 is tightly Address correspondence and reprint requests to Dr. Helena Paidassi, Centre Interna- regulated in DCs. Although the av subunit, the only known partner tional de Recherche en Infectiologie, 21, Avenue Tony Garnier, 69365 Lyon Cedex of b8 (12), is ubiquitously expressed, b8 expression is restricted to 07, France. E-mail address: [email protected] specific subsets of cells in the intestine (8). Under homeostatic The online version of this article contains supplemental material. conditions, avb8 is expressed predominantly on DCs from mes- Abbreviations used in this article: DC, dendritic cell; FL-DC, bone marrow–derived DC generated in the presence of Flt3-ligand; IRF, IFN regulatory factor; KO, knock- enteric lymph nodes (MLN) and intestinal lamina propria (LP) that out; LP, lamina propria; l-TGF-b, latent TGF-b; MLN, mesenteric lymph node; express the mucosal integrin aEb7 (CD103), conferring on these ODN, oligodeoxynucleotide; RA, retinoic acid; Treg, regulatory T cell; TRIF, Toll/ cells their preferential ability to activate TGF-b and generate Tregs IL-1R domain–containing adapter-inducting IFN-b; VAD, vitamin A–deficient. (8, 9). CD103+ DCs have previously been implicated in the gen- Copyright Ó 2016 by The American Association of Immunologists, Inc. 0022-1767/16/$30.00 eration of intestinal Tregs, which has also been attributed to their www.jimmunol.org/cgi/doi/10.4049/jimmunol.1600244 2 b8 INTEGRIN EXPRESSION IN DENDRITIC CELLS ability to synthesize all-trans retinoic acid (RA) that promotes Treg General Hospital). Tgfbr2fl/fl mice (B6.129S6-Tgfbr2tm1Hlm) were obtained from H. Moses (13) (Vanderbilt-Ingram Cancer Center, Nashville, TN). generation in the presence of TGF-b. These data therefore support IRES-eGFP the concept that subsets of intestinal DCs are specialized for gen- Foxp3 reporter mice were obtained from D. Kaiserlian (Centre In- ternational de Recherche en Infectiologie). All mice were on C57BL/6 eration of Tregs. However, the precise mechanisms by which this background, except for Tgfbr2-flox mice, which were on a mixed B6.129S6 population of DCs acquires this specialized ability to activate TGF-b background. Animal experiments were performed under appropriate licenses and how microenvironmental cues and cell lineage are integrated in within local and national guidelines for animal care. this process remain to be fully determined. DC isolation In this study, we set out to identify the signals that regulate b8 expression in intestinal DCs. We report that avb8 is expressed DCs from spleen, MLN, and LP were isolated as previously described (8). + 2 Bone marrow–derived DCs generated in the presence of Flt3-ligand (FL-DCs) preferentially on the CD103 CD11b subset of DCs in the MLNs, were cultured, as previously described (14). Briefly, bone marrow cells were and that expression is acquired in the LP. We show that signals cultured in the presence of 100 ng/ml recombinant Flt3-ligand (PeproTech, from the mucosal microenvironment, specifically TGF-b, RA, and Neuilly-sur-Seine, France). Fresh medium was added to the cultures on day 3 TLR agonists, together promote expression of b8 integrin in DCs and 6, and cells were harvested at day 9. FL-DC subsets were then sorted by and that inhibition of signaling through these pathways in mice flow cytometry, as indicated.
Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
  • TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the Myd88 Signaling Pathway Augments the Innate Immune Response

    TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the Myd88 Signaling Pathway Augments the Innate Immune Response

    cells Article TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response 1 2, 1 3 Hellen S. Teixeira , Jiawei Zhao y, Ethan Kazmierski , Denis F. Kinane and Manjunatha R. Benakanakere 2,* 1 Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19004, USA; [email protected] (H.S.T.); [email protected] (E.K.) 2 Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19004, USA; [email protected] 3 Periodontology Department, Bern Dental School, University of Bern, 3012 Bern, Switzerland; [email protected] * Correspondence: [email protected] Present address: Department of Pathology, Wayne State University School of Medicine, y 541 East Canfield Ave., Scott Hall 9215, Detroit, MI 48201, USA. Received: 30 June 2020; Accepted: 12 August 2020; Published: 17 August 2020 Abstract: The role of the adaptor molecule MyD88 is thought to be independent of Toll-like receptor 3 (TLR3) signaling. In this report, we demonstrate a previously unknown role of MyD88 in TLR3 signaling in inducing endogenous ligands of TLR2 to elicit innate immune responses. Of the various TLR ligands examined, the TLR3-specific ligand polyinosinic:polycytidylic acid (poly I:C), significantly induced TNF production and the upregulation of other TLR transcripts, in particular, TLR2. Accordingly, TLR3 stimulation also led to a significant upregulation of endogenous TLR2 ligands mainly, HMGB1 and Hsp60. By contrast, the silencing of TLR3 significantly downregulated MyD88 and TLR2 gene expression and pro-inflammatory IL1β, TNF, and IL8 secretion. The silencing of MyD88 similarly led to the downregulation of TLR2, IL1β, TNF and IL8, thus suggesting MyD88 / to somehow act downstream of TLR3.
  • Cd8a (Ly-2) Microbeads Mouse

    Cd8a (Ly-2) Microbeads Mouse

    CD8a (Ly-2) MicroBeads mouse Order no. 130-049-401 Contents 1.2 Background information 1. Description Mouse CD8a (Ly-2) MicroBeads were developed for positive + 1.1 Principle of the MACS® Separation selection or depletion of mouse CD8a T cells from single-cell suspensions of lymphoid and non-lymphoid tissues or from 1.2 Background information peripheral blood. The CD8a antigen is expressed on most 1.3 Applications thymocytes, almost all cytotoxic T cells and on subpopulations of dendritic cells. CD8a functions as an accessory molecule in 1.4 Reagent and instrument requirements the recognition of MHC class I/peptide complexes by the TCR 2. Protocol heterodimer on cytotoxic CD8a+ T cells. 2.1 Sample preparation 1.3 Applications 2.2 Magnetic labeling + 2.3 Magnetic separation ● Positive selection or depletion of CD8a T cells from lymphoid organs, non-lymphoid tissue, peripheral blood, or in vitro 2.4 Cell separation with the autoMACS® Pro Separator cultured cells. 3. Example of a separation using the CD8a (Ly-2) MicroBeads + ● Isolation of purified CD8 cells for in vitro and in vivo studies 1,2 4. References on protective immune responses against parasites or allergens3, and for adoptive transfer into immunodeficient4,5 and virus infected mice6. + Warnings ● Isolation of highly pure CD8 T cells from CNS of MHV infected 7 Reagents contain sodium azide. Under acidic conditions sodium mice for evaluation of their chemokine expression pattern. azide yields hydrazoic acid, which is extremely toxic. Azide compounds should be diluted with running water before discarding. 1.4 Reagent and instrument requirements These precautions are recommended to avoid deposits in plumbing ● Buffer: Prepare a solution containing phosphate-buffered where explosive conditions may develop.
  • Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma

    Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma

    ARTICLE https://doi.org/10.1038/s41467-020-16164-1 OPEN Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Nayoung Kim 1,2,3,13, Hong Kwan Kim4,13, Kyungjong Lee 5,13, Yourae Hong 1,6, Jong Ho Cho4, Jung Won Choi7, Jung-Il Lee7, Yeon-Lim Suh8,BoMiKu9, Hye Hyeon Eum 1,2,3, Soyean Choi 1, Yoon-La Choi6,10,11, Je-Gun Joung1, Woong-Yang Park 1,2,6, Hyun Ae Jung12, Jong-Mu Sun12, Se-Hoon Lee12, ✉ ✉ Jin Seok Ahn12, Keunchil Park12, Myung-Ju Ahn 12 & Hae-Ock Lee 1,2,3,6 1234567890():,; Advanced metastatic cancer poses utmost clinical challenges and may present molecular and cellular features distinct from an early-stage cancer. Herein, we present single-cell tran- scriptome profiling of metastatic lung adenocarcinoma, the most prevalent histological lung cancer type diagnosed at stage IV in over 40% of all cases. From 208,506 cells populating the normal tissues or early to metastatic stage cancer in 44 patients, we identify a cancer cell subtype deviating from the normal differentiation trajectory and dominating the metastatic stage. In all stages, the stromal and immune cell dynamics reveal ontological and functional changes that create a pro-tumoral and immunosuppressive microenvironment. Normal resident myeloid cell populations are gradually replaced with monocyte-derived macrophages and dendritic cells, along with T-cell exhaustion. This extensive single-cell analysis enhances our understanding of molecular and cellular dynamics in metastatic lung cancer and reveals potential diagnostic and therapeutic targets in cancer-microenvironment interactions. 1 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea.
  • Supplementary Table 1: Adhesion Genes Data Set

    Supplementary Table 1: Adhesion Genes Data Set

    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
  • Changes in Peripheral and Local Tumor Immunity After Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer Margaret L

    Changes in Peripheral and Local Tumor Immunity After Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer Margaret L

    Published OnlineFirst August 21, 2020; DOI: 10.1158/1078-0432.CCR-19-3685 CLINICAL CANCER RESEARCH | TRANSLATIONAL CANCER MECHANISMS AND THERAPY Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer Margaret L. Axelrod1, Mellissa J. Nixon1, Paula I. Gonzalez-Ericsson2, Riley E. Bergman1, Mark A. Pilkinton3, Wyatt J. McDonnell3, Violeta Sanchez1,2, Susan R. Opalenik1, Sherene Loi4, Jing Zhou5, Sean Mackay5, Brent N. Rexer1, Vandana G. Abramson1, Valerie M. Jansen1, Simon Mallal3, Joshua Donaldson1, Sara M. Tolaney6, Ian E. Krop6, Ana C. Garrido-Castro6, Jonathan D. Marotti7,8, Kevin Shee9, Todd. W. Miller8,9, Melinda E. Sanders2,10, Ingrid A. Mayer1,2, Roberto Salgado4,11, and Justin M. Balko1,2 ABSTRACT ◥ Purpose: The recent approval of anti-programmed death-ligand Results: In non-TNBC, no change in expression of any single 1 immunotherapy in combination with nab-paclitaxel for meta- gene was associated with RFS or OS, while in TNBC upregulation of static triple-negative breast cancer (TNBC) highlights the need to multiple immune-related genes and gene sets were associated with understand the role of chemotherapy in modulating the tumor improved long-term outcome. High cytotoxic T-cell signatures immune microenvironment (TIME). present in the peripheral blood of patients with breast cancer at Experimental Design: We examined immune-related gene surgery were associated with persistent disease and recurrence, expression patterns before and after neoadjuvant chemotherapy suggesting active antitumor immunity that may indicate ongoing (NAC) in a series of 83 breast tumors, including 44 TNBCs, from disease burden. patients with residual disease (RD).
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells

    CD Markers Are Routinely Used for the Immunophenotyping of Cells

    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
  • BTLA−HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a Cona-Induced Hepatitis Model in Zebrafish

    BTLA−HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a Cona-Induced Hepatitis Model in Zebrafish

    BTLA−HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish This information is current as Wei Shi, Tong Shao, Jiang-yuan Li, Dong-dong Fan, Ai-fu of September 27, 2021. Lin, Li-xin Xiang and Jian-zhong Shao J Immunol published online 27 September 2019 http://www.jimmunol.org/content/early/2019/09/26/jimmun ol.1900458 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/09/26/jimmunol.190045 Material 8.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published September 27, 2019, doi:10.4049/jimmunol.1900458 The Journal of Immunology BTLA–HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish Wei Shi,* Tong Shao,* Jiang-yuan Li,* Dong-dong Fan,* Ai-fu Lin,* Li-xin Xiang,* and Jian-zhong Shao*,† The BTLA2HVEM checkpoint axis plays extensive roles in immunomodulation and diseases, including cancer and autoimmune disorders.
  • Roles of Activating Functions 1 and 2 of Estrogen Receptor Α in Lymphopoiesis

    Roles of Activating Functions 1 and 2 of Estrogen Receptor Α in Lymphopoiesis

    236 2 Journal of A Andersson et al. ERαAF-1 and ERαAF-2 in 236:2 99–109 Endocrinology ER-mediated immunomodulation RESEARCH Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis Annica Andersson1, Anna E Törnqvist2, Sofia Moverare-Skrtic2, Angelina I Bernardi1, Helen H Farman2, Pierre Chambon3, Cecilia Engdahl1,2, Marie K Lagerquist2, Sara H Windahl2, Hans Carlsten1, Claes Ohlsson2 and Ulrika Islander1 1Centre for Bone and Arthritis Research, Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 2Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 3Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, National de la Sante et de la Recherche Medicale, ULP, Collège de France, Illkirch-Strasbourg, France Correspondence should be addressed to A Andersson: [email protected] Abstract Apart from the role of sex steroids in reproduction, sex steroids are also important Key Words regulators of the immune system. 17β-estradiol (E2) represses T and B cell development, f lymphopoiesis but augments B cell function, possibly explaining the different nature of immune f estrogen receptor alpha responses in men and women. Both E2 and selective estrogen receptors modulators f estradiol (SERM) act via estrogen receptors (ER). Activating functions (AF)-1 and 2 of the ER f selective estrogen bind to coregulators and thus influence target gene transcription and subsequent receptor modulators cellular response to ER activation. The importance of ERαAF-1 and AF-2 in the immunomodulatory effects of E2/SERM has previously not been reported.
  • The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic In�Ammation and the Formation of Abdominal Aortic Aneurysms

    The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic InAmmation and the Formation of Abdominal Aortic Aneurysms

    The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang Karolinska Institute Evelyn Hutterer Karolinska Institute Sara Hultin Karolinska Institute Otto Bergman Karolinska Institute Maria Forteza Karolinska Institute Zorana Andonovic Karolinska Institute Daniel Ketelhuth Karolinska University Hospital, Stockholm, Sweden Joy Roy Karolinska Institute Per Eriksson Karolinska Institute Lars Holmgren ( [email protected] ) Karolinska Institute Article Keywords: arterial endothelial cells (ECs), vascular disease, abdominal aortic aneurysms Posted Date: June 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-600069/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang1, Evelyn Hutterer1, Sara Hultin1, Otto Bergman2, Maria J. Forteza2, Zorana Andonovic1, Daniel F.J. Ketelhuth2,3, Joy Roy4, Per Eriksson2 and Lars Holmgren1*. 1Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, Sweden. 2Department of Medicine Solna, BioClinicum, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 3Department of Cardiovascular and Renal Research, Institutet of Molecular Medicine, Univ. of Southern Denmark, Odense, Denmark 4Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm,
  • NF-Κb Signaling and Its Relevance to the Treatment of Mantle Cell Lymphoma

    NF-Κb Signaling and Its Relevance to the Treatment of Mantle Cell Lymphoma

    Balaji et al. Journal of Hematology & Oncology (2018) 11:83 https://doi.org/10.1186/s13045-018-0621-5 REVIEW Open Access NF-κB signaling and its relevance to the treatment of mantle cell lymphoma Swathi Balaji, Makhdum Ahmed, Elizabeth Lorence, Fangfang Yan, Krystle Nomie and Michael Wang* Abstract Mantle cell lymphoma is an aggressive subtype of non-Hodgkin B cell lymphoma that is characterized by a poor prognosis determined by Ki67 and Mantle Cell International Prognostic Index scores, but it is becoming increasingly treatable. The majority of patients, especially if young, achieve a progression-free survival of at least 5 years. Mantle cell lymphoma can initially be treated with an anti-CD20 antibody in combination with a chemotherapy backbone, such as VR-CAP (the anti-CD20 monoclonal antibody rituximab administered with cyclophosphamide, doxorubicin, and prednisone) or R-CHOP (the anti-CD20 monoclonal antibody rituximab administered with cyclophosphamide, doxorubicin, vincristine, and prednisone). While initial treatment can facilitate recovery and complete remission in a few patients, many patients experience relapsed or refractory mantle cell lymphoma within 2 to 3 years after initial treatment. Targeted agents such as ibrutinib, an inhibitor of Bruton’s tyrosine kinase, which has been approved only in the relapsed setting, can be used to treat patients with relapsed or refractory mantle cell lymphoma. However, mantle cell lymphoma cells often acquire resistance to such targeted agents and continue to survive by activating alternate signaling pathways such as the PI3K-Akt pathway or the NF-κB pathways. NF-κB is a transcription factor family that regulates the growth and survival of B cells; mantle cell lymphoma cells depend on NF-κB signaling for continued growth and proliferation.
  • And Maintenance of Peripheral T Cells Locus Controls IL-7 Receptor

    And Maintenance of Peripheral T Cells Locus Controls IL-7 Receptor

    An Enhancer of the IL-7 Receptor α-Chain Locus Controls IL-7 Receptor Expression and Maintenance of Peripheral T Cells This information is current as Akifumi Abe, Shizue Tani-ichi, Soichiro Shitara, Guangwei of October 2, 2021. Cui, Hisataka Yamada, Hitoshi Miyachi, Satsuki Kitano, Takahiro Hara, Ryo Abe, Yasunobu Yoshikai and Koichi Ikuta J Immunol 2015; 195:3129-3138; Prepublished online 2 September 2015; doi: 10.4049/jimmunol.1302447 Downloaded from http://www.jimmunol.org/content/195/7/3129 Supplementary http://www.jimmunol.org/content/suppl/2015/09/01/jimmunol.130244 http://www.jimmunol.org/ Material 7.DCSupplemental References This article cites 46 articles, 26 of which you can access for free at: http://www.jimmunol.org/content/195/7/3129.full#ref-list-1 Why The JI? Submit online. by guest on October 2, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology An Enhancer of the IL-7 Receptor a-Chain Locus Controls IL-7 Receptor Expression and Maintenance of Peripheral T Cells Akifumi Abe,*,† Shizue Tani-ichi,* Soichiro Shitara,*,† Guangwei Cui,*,‡ Hisataka Yamada,x Hitoshi Miyachi,{ Satsuki Kitano,{ Takahiro Hara,* Ryo Abe,‖ Yasunobu Yoshikai,x and Koichi Ikuta* The IL-7R plays critical roles in lymphocyte development and homeostasis.